"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 5 | 5 |
| 2002 | 0 | 6 | 6 |
| 2003 | 0 | 5 | 5 |
| 2004 | 0 | 9 | 9 |
| 2005 | 0 | 14 | 14 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 17 | 17 |
| 2008 | 0 | 12 | 12 |
| 2009 | 0 | 29 | 29 |
| 2010 | 0 | 20 | 20 |
| 2011 | 0 | 27 | 27 |
| 2012 | 0 | 27 | 27 |
| 2013 | 1 | 33 | 34 |
| 2014 | 0 | 38 | 38 |
| 2015 | 0 | 44 | 44 |
| 2016 | 0 | 42 | 42 |
| 2017 | 2 | 46 | 48 |
| 2018 | 0 | 43 | 43 |
| 2019 | 0 | 43 | 43 |
| 2020 | 0 | 46 | 46 |
| 2021 | 0 | 37 | 37 |
| 2022 | 0 | 17 | 17 |
| 2023 | 1 | 4 | 5 |
| 2024 | 0 | 11 | 11 |
| 2025 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Explainable transformer-based deep survival analysis in childhood acute lymphoblastic leukemia. Comput Biol Med. 2025 Jun; 191:110118.
-
Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes. Leukemia. 2025 Apr; 39(4):942-950.
-
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Ann Surg. 2025 May 01; 281(5):852-860.
-
Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.
-
The Utilization of PRAME in the Diagnosis, Prognosis, and Treatment of Melanoma. Cells. 2024 Oct 20; 13(20).
-
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clin Cancer Res. 2024 Aug 01; 30(15):3167-3178.
-
Mortality After Procedural or Spontaneous Myocardial Infarction. J Am Coll Cardiol. 2024 Jul 30; 84(5):467-477.
-
Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations. Lancet Oncol. 2024 Jul; 25(7):e297-e307.
-
Prognostic value of preoperative mechanical hyperalgesia and neuropathic pain qualities for postoperative pain after total knee replacement. Eur J Pain. 2024 Sep; 28(8):1387-1401.
-
Chordoma: Genetics and Contemporary Management. Int J Mol Sci. 2024 May 28; 25(11).